We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Lexology logo






  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 1,106

SCCS says parabens in cosmetics are safe

  • Shook Hardy & Bacon LLP
  • -
  • European Union
  • -
  • June 13 2013

The European Union's (EU's) Scientific Committee on Consumer Safety (SCCS) has updated its opinion on propyl- and butylparabenchemical

CSPI calls on FDA to ban Ginkgo products

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • June 13 2013

In a letter to the U.S. Food and Drug Administration (FDA), the Center for Science in the Public Interest (CSPI) has urged the agency to ban the use

APHA’s annual meeting to include sessions on food taxation, labeling, marketing, and legal strategies

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • June 7 2013

The American Public Health Association's 141st annual meeting and exposition is slated for November 2-6, 2013, in Boston, Massachusetts. Expected to

NYC Health Department expands campaign to all sweetened beverages

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • June 7 2013

The New York City (NYC) Department of Health and Mental Hygiene has reportedly launched an ad campaign targeting beverages with added sugars, such as

CRS issues report on compounded drugs

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • June 6 2013

The Congressional Research Service (CRS) has issued a report titled "Compounded Drugs" to address the risks and oversight issues raised by the

Industry experts meet in Russia to discuss harmonized biologic regulations

  • Shook Hardy & Bacon LLP
  • -
  • Russia
  • -
  • June 6 2013

Regulators and representatives of Russia's drug industry met recently with the goal of developing an outline of standards for the evaluation and

FDA seeks premarket notification for mobile medical application

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • June 6 2013

The U.S. Food and Drug Administration (FDA) has informed an India-based company that it is expected to file a premarket notification as to its uChek

U.S. biotech sector shows IPO gains in 2013

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • June 6 2013

According to Reuters, 14 biotech companies have gone public so far in 2013, marking a possible turnaround for the sector with a rising stock market

News Bytes - June 6, 2013

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • June 6 2013

The U.S. Patent and Trademark Office creates the After Final Consideration Pilot Program 2.0 which modifies and extends a program designed to

FDA warns companies about links to web sites with health benefit claims

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • May 31 2013

The U.S Food and Drug Administration (FDA) recently issued a warning letter to dietary supplement manufacturer EuroPharma, Inc., stating that because

Current Search

Suggested Facets

Author

Jurisdiction

Workarea

© Copyright 2006-2013 Globe Business Publishing Ltd | Cookies | Disclaimer | Privacy policy